Agilent to acquire digital pathology firm Proscia for up to $270M
Agilent will acquire Proscia for up to $270M to expand its digital pathology, AI-based diagnostics and biopharma research capabilities. The news appeared on October 12.
Who is affected and how
- doctor
- For pathologists, the vendor side of digital, AI-assisted workflows is consolidating.
- medtech company
- The wave of acquisitions among diagnostics players is creating competitive pressure.
- pharmaceuticals
- Biopharma research may also gain access to digital pathology capabilities.
Sources
- Why Agilent Is Spending up to $270 Million on an AI Pathology Specialistbenzinga.com · Oct 12, 2026
- Agilent to buy pathology software maker Proscia for $240 millionfinance.yahoo.com · Oct 13, 2026
- Agilent to Acquire Proscia for Up to $270Mvohnetwork.com · Oct 12, 2026
- Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence - BioSpacebiospace.com · Oct 13, 2026 · magyar
- Agilent to Acquire Proscia for Up to $270M to Build Scientific Intelligence Layer in Digital Pathology - HIT Consultanthitconsultant.net · Oct 13, 2026 · magyar
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.